DIN 02309238 — BREVIBLOC PREMIXED INJECTION 10 MG
BREVIBLOC PREMIXED INJECTION is a solution of Esmolol hydrochloride marketed by BAXTER CORPORATION. The full Esmolol hydrochloride monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02309238
- Brand name
- BREVIBLOC PREMIXED INJECTION
- Active ingredient
- Esmolol hydrochloride
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BAXTER CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Ultra-short-acting cardioselective beta-1 adrenergic blocker (IV-only beta blocker)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Esmolol hydrochloride products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02188880 | BREVIBLOC INJECTION 10MG/ML | 10 MG | SOLUTION | BAXTER CORPORATION | MARKETED |